← Open Payments lookup

ANN CUDNEY: Open Payments

NPI 1396384426 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,048 in 68 payments from 9 companies in 2025. Trend: 2023 $623 · 2024 $856 · 2025 $1,048

Food & beverage: $1,048
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.19$299
Teva Pharmaceuticals USA, Inc.12$179
Otsuka America Pharmaceutical, Inc.12$170
E.R. Squibb & Sons, L.L.C.12$141
Supernus Pharmaceuticals, Inc.4$85
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$65
Janssen Pharmaceuticals, Inc3$49
ABBVIE INC.2$39
Alkermes, Inc.1$20

Products named: INGREZZA, COBENFY, UZEDY, Qelbree, REXULTI, AUSTEDO XR, ABILIFY MAINTENA, CAPLYTA.

Industry payments across MI — which companies pay providers there.